<http://webisa.webdatacommons.org/210516454>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/210516454>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<earthlink.net> .
<http://webisa.webdatacommons.org/prov/472200366>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/210516454> .
<http://webisa.webdatacommons.org/210516454>	<http://www.w3.org/ns/prov#value>	"However our main interest now is in MS, and our first objective is to have the placenta implant used in 10+ MS patients, hoping to collect enough data, to enable us to submit to the FDA, the Center of Biological Research (CBER) an Investigational New Drug (IND) application for a biological product." .